Skip to main content

This site is intended for u.s. healthcare professionals

U.S. full prescribing information

AGITATION ASSOCIATED
WITH DEMENTIA DUE TO
ALZHEIMER’S DISEASE

select the Indication Agitation associated with dementia due to Alzheimer’s disease

AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER’S DISEASE
MAJOR DEPRESSIVE DISORDER (ADJUNCTIVE)
SCHIZOPHRENIA (SZ)

Partial
Response
- Is Partial Response Good Enough?
- Patient Profiles
Efficacy
Data
- Primary Endpoint
- Study Design Summary
Non-Pivotal
Study Data
- Additional Analysis
- Post hoc Analysis
Safety
Profile
Clinical
Pharmacology
Dosing &
Titration
Savings &
Coverage
Resources
- For Your Patients
- For Your Practice

Efficacy
Data
Safety
Profile
Patient
Profile
Clinical
Pharmacology
Dosing &
Titration
Savings &
Coverage
Resources
- For Your Patients
- For Your Practice

Symptoms
- Symptoms
- Disease Burden
Efficacy
Data
Safety
Profile
Dosing &
Titration
- Dosing & Titration Schedule
- Dose Adjustments
Patient/Caregiver
Profiles
Clinical
Pharmacology
Savings &
Coverage
Resources
- For Your Patients and Caregivers
- For Your Practice

Request a Rep
Find Speaker Programs
For Patients AND& Caregivers

select the Indication Agitation associated with dementia due to Alzheimer’s disease

AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER’S DISEASE
MAJOR DEPRESSIVE DISORDER (ADJUNCTIVE)
SCHIZOPHRENIA (SZ)

Partial
Response
- Is Partial Response Good Enough?
- Patient Profiles
Efficacy
Data
- Primary Endpoint
- Study Design Summary
Non-Pivotal
Study Data
- Additional Analysis
- Post hoc Analysis
Safety
Profile
Clinical
Pharmacology
Dosing &
Titration
Savings &
Coverage
Resources
- For Your Patients
- For Your Practice

Efficacy
Data
Safety
Profile
Patient
Profile
Clinical
Pharmacology
Dosing &
Titration
Savings &
Coverage
Resources
- For Your Patients
- For Your Practice

Symptoms
- Symptoms
- Disease Burden
Efficacy
Data
Safety
Profile
Dosing &
Titration
- Dosing & Titration Schedule
- Dose Adjustments
Patient/Caregiver
Profiles
Clinical
Pharmacology
Savings &
Coverage
Resources
- For Your Patients and Caregivers
- For Your Practice

Skip to Important Safety Information

Clinical Pharmacology

REXULTI® (brexpiprazole) has high binding affinity^a to 3 neurotransmitter systems: norepinephrine, serotonin, and dopamine^1,2